Patient Guide: Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 61 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06236438
Status: 🟢 Enrolling Now
Condition: Non-Small Cell Lung Cancer
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 61 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • La Jolla, California
  • Pembroke Pines, Florida
  • Winter Haven, Florida
  • • And 58 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily